- $499.19m
- $470.91m
- $320.17m
AngioDynamics down on wider loss forecast
Brief: AngioDynamics Q2 Adjusted EPS USD -0.05 Vs. IBES Estimate USD -0.07
AngioDynamics Inc expected to post a loss of 7 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Elf Beauty, PTC Therapeutics, Shoals Technologies Group
AngioDynamics Inc reports results for the quarter ended in August - Earnings Summary
Brief: AngioDynamics Q1 Adjusted EPS USD -0.12 Vs. IBES Estimate USD -0.13
AngioDynamics Inc expected to post a loss of 13 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Nu Holdings, United States Steel, Mallinckrodt
U.S. STOCKS ON THE MOVE-Chevron, Coherent, HF Sinclair
U.S. STOCKS ON THE MOVE-Eyenovia, TJX Cos, H & R Block
U.S. STOCKS ON THE MOVE-Nvidia, DLocal, Target
AngioDynamics up on FDA's breakthrough tag for heart device
Brief: Angiodynamics Receives FDA Breakthrough Device Designation For Angiovac System For Non-Surgical Removal Of Right Heart Vegetation
Brief: Angiodynamics Announces Addition Of Lorinda Burgess To Board Of Directors
U.S. RESEARCH ROUNDUP- Diamondback Energy, Penumbra, Procore Technologies
U.S. STOCKS ON THE MOVE-Liminal Biosciences, Tesla, Quad/Graphics
U.S. STOCKS ON THE MOVE-T2 Biosystems, GoodRx Holdings, ShiftPixy
AngioDynamics Inc reports results for the quarter ended in May - Earnings Summary
U.S. STOCKS ON THE MOVE-Domino's Pizza, Amazon, Salesforce